RENOVORX, INC.
Last · NASDAQ$1.12-0.03 (-2.61%)close · yahoo · 15h ago
Market cap$50.55M45.1M sh
P/E · TTM-3.7fwd -9.3 · eps -0.30 · loss
Beta0.97vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.701$2.59
Volume628.0Ksession
| Revenue | $1.5M |
|---|---|
| Operating income | $-6.8M |
| Net income | $-6.4M |
| Free cash flow | $-6.6M |
| Operating margin | -463.2% |
| Net margin | -437.0% |
| Return on equity | -71.6% |
| Period | 2026 |
Loading chart…
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.05
Est. revenue
1.1M
Earnings transcripts
Press & signals
- GlobeNewswire
RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth